Literature DB >> 127794

Increase in dissociation rate constants of cardiotonic steroid-brain (Na+ + K+)-ATPase complexes by reduction of the unsaturated lactone.

A F Clark, P D Swanson, W L Stahl.   

Abstract

Several cardiotonic steroids have been modified by reduction of the unsaturated lactone and their interactions with the sodium- and potassium-activated ATPase ((Na+ + K+)-ATPase) have been investigated. Reduction of the unsaturated lactone results in a decrease in binding affinity due primarily to an increase in the dissociation rate constant concomitant with a decrease in the activation free energy of dissociation. This decrease in activation free energy is about 2 to 4 kcal, which is approximately equal to the energy of one hydrogen bond. It is suggested that the increase in dissociation rate due to reduction of the unsaturated lactone may make possible the use of these compounds as affinity ligands for purification of the (Na+ + K+)-ATPase or an ouabain-binding fragment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 127794

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Factors influencing the onset of ouabain inhibition of Na,K-ATPase from guinea-pig myocardium.

Authors:  F Ebner
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

2.  Influence of 16 beta formylation on Na, K-ATPase inhibition by cardiac glycosides.

Authors:  A De Pover; T Godfraind
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-11       Impact factor: 3.000

3.  Heart failure drug digitoxin induces calcium uptake into cells by forming transmembrane calcium channels.

Authors:  Nelson Arispe; Juan Carlos Diaz; Olga Simakova; Harvey B Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

4.  How fast do cardioactive steroids act independently of diffusion in guinea-pig myocardium?

Authors:  F Ebner
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.